Survival And Its Determinant Of Multidrug-resistant Tuberculosis Patients With (hiv) Co-infection St. Peter Tuberculosis Specialized Hospital Addis Ababa Ethiopia

Back groundrnAccording to World Health Organization (WHO) 2015 report globally 480 000 new cases and 190,000 estimated deaths occurred in 2014 due to MDR TB. Ethiopia ranked 7th from top 22 highest TB-burden and 15th from 27 highest MDR-TB burden countries; and one of high HIV/AIDS prevalent in Sub-Sahara African countries. Nevertheless, a little known about Survival of Multidrug-resistant Tuberculosis patients with HIV/AIDS co-infection in Ethiopia. Hence, this study is to determine the Survival and their determinants in MDR TB patients co-infected with HIV/AIDS Addis Ababa, EthiopiarnMethodrnA retrospective cohort study design was conduct at St. Peter TB specialized hospital Addis Ababa, Ethiopia; from February to March 2016. Survival of exposed and non-exposed groups was compared by Kaplan-Meier survival functions by using log-rank test. Factors that associated with outcome variables at 20 % (p

Get Full Work

Report copyright infringement or plagiarism